Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia-Reference-Cited by-同舟云学术

Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia

Published:2012-06-10 Issue:7 Volume:18 Page:1118-1122
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kentsis Alex,Reed Casie,Rice Kim L,Sanda Takaomi,Rodig Scott J,Tholouli Eleni,Christie Amanda,Valk Peter J M,Delwel Ruud,Ngo Vu,Kutok Jeffery L,Dahlberg Suzanne E,Moreau Lisa A,Byers Richard J,Christensen James G,Woude George Vande,Licht Jonathan D,Kung Andrew L,Staudt Louis M,Look A Thomas

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2819.pdf

Reference26 articles.

1. Grimwade, D. et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98, 1312–1320 (2001).

2. Burnett, A., Wetzler, M. & Lowenberg, B. Therapeutic advances in acute myeloid leukemia. J. Clin. Oncol. 29, 487–494 (2011).

3. Westbrook, T.F., Stegmeier, F. & Elledge, S.J. Dissecting cancer pathways and vulnerabilities with RNAi. Cold Spring Harb. Symp. Quant. Biol. 70, 435–444 (2005).

4. Bernards, R., Brummelkamp, T.R. & Beijersbergen, R.L. shRNA libraries and their use in cancer genetics. Nat. Methods 3, 701–706 (2006).

5. Ngo, V.N. et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106–110 (2006).

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis-Related Gene Signature for Prognosis Prediction in Acute Myeloid Leukemia and Potential Therapeutic Options;International Journal of General Medicine;2024-09

2. Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment;International Journal of Molecular Sciences;2024-08-22

3. T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including hepatocyte growth factor;Biomedicine & Pharmacotherapy;2024-08

4. Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy;Cancer Discovery;2024-06-03

5. T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including Hepatocyte Growth factor;2024-04-26